Back to search

United Kingdom· GB-APID-14026711000001100

NovoPen 4 hypodermic insulin injection pen reusable for 3ml cartridge 1 unit dial up / range 1-60 units

A medicinal product, registered in United Kingdom by Novo Nordisk Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedNovoPen 4 hypodermic insulin injectio…ATC—REGISTER NO.GB-APID-1402671100000…PACKS LISTED1CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Manufacturer
Novo Nordisk Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5017954001576

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ce9fe89a-84a2-4cba-88e5-42774af7f7c8
GET /v1/drugs/ce9fe89a-84a2-4cba-88e5-42774af7f7c8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "14026711000001100",
  "desc": "NovoPen 4 hypodermic insulin injection pen reusable for 3ml cartridge 1 unit dial up / range 1-60 units Blue (Novo Nordisk Ltd)",
  "form": null,
  "vpid": "3754411000001104",
  "source": "dmd",
  "vtm_id": null,
  "strength": null,
  "substance": null,
  "ingredient": null,
  "supplier_code": "2080301000001101"
}

See everything about NovoPen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.